When a JAK Inhibitor Fails

What Are the Therapeutic Alternatives When a Janus Kinase Inhibitor Fails to Work? SAN DIEGO—Treatment alternatives after Janus kinase (JAK) inhibitor failure in real-life conditions were analyzed and presented at ACR Convergence 2023 by Pablo Francisco Muñoz Martínez, a rheumatologist at the Hospital Universitario y Politécnico La Fe, Sagunto, Spain.1 JAK inhibitors are newer, targeted...
Source: The Rheumatologist - Category: Rheumatology Authors: Tags: ACR Convergence Biologics/DMARDs Drug Updates ACR Convergence 2023 JAK inhibitors Janus Kinase Inhibitors Source Type: research